Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-25 @ 12:36 AM
NCT ID:
NCT04581967
Eligibility Criteria:
Inclusion Criteria:
1. Confirmed diagnosis of breast cancer.
2. Age ranging from 18 to 75 years old female.
3. Patients will take Doxorubicin-Cyclophosphamide regimen as chemotherapy treatment.
Exclusion Criteria:
1. Any other malignancy.
2. Previous treatment for metastatic disease.
3. Pregnancy or breastfeeding female.
4. Inadequate bone marrow and cardiac function.
5. Serious or uncontrolled medical conditions.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT04581967
Study Brief:
Protocol Section:
NCT04581967